Endometrial cancer cells with a high ALDH1 expression were found to be more tumorigenic and invasive, as well as resistant to cisplatin therapy and associated with a worse prognosis in patients with endometrial cancer (p = 0.01 for overall survival), compared with cells with a low expression of ALDH1. The gene discussed is ALDH1A1; the disease is endometrial cancer.